The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
In this report, we mainly study the drugs and eye drops for dry eye.
The global Dry Eye Syndrome Treatment market was valued at US$ 5385 million in 2023 and is anticipated to reach US$ 7375.6 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Dry Eye Syndrome Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Eye Syndrome Treatment.
Report Scope
The Dry Eye Syndrome Treatment market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Eye Syndrome Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dry Eye Syndrome Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Novartis
- Allergan
- Otsuka
- Santen Pharmaceutical
- Nicox
- Auven Therapeutics
- Akorn
- Bausch & Lomb
- Alimera
- GlaxoSmithKline
Segment by Type
- Liquid Drops
- Gel
- Liquid Wipes
- Eye Ointment
- Other
Segment by Application
- Hospital
- Clinic
- Home Care
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dry Eye Syndrome Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dry Eye Syndrome Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Dry Eye Syndrome Treatment Market Overview
1.1 Product Overview and Scope of Dry Eye Syndrome Treatment
1.2 Dry Eye Syndrome Treatment Segment by Type
1.2.1 Global Dry Eye Syndrome Treatment Market Value Comparison by Type (2024-2030)
1.2.2 Liquid Drops
1.2.3 Gel
1.2.4 Liquid Wipes
1.2.5 Eye Ointment
1.2.6 Other
1.3 Dry Eye Syndrome Treatment Segment by Application
1.3.1 Global Dry Eye Syndrome Treatment Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.4 Global Dry Eye Syndrome Treatment Market Size Estimates and Forecasts
1.4.1 Global Dry Eye Syndrome Treatment Revenue 2019-2030
1.4.2 Global Dry Eye Syndrome Treatment Sales 2019-2030
1.4.3 Global Dry Eye Syndrome Treatment Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dry Eye Syndrome Treatment Market Competition by Manufacturers
2.1 Global Dry Eye Syndrome Treatment Sales Market Share by Manufacturers (2019-2024)
2.2 Global Dry Eye Syndrome Treatment Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Dry Eye Syndrome Treatment Average Price by Manufacturers (2019-2024)
2.4 Global Dry Eye Syndrome Treatment Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dry Eye Syndrome Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dry Eye Syndrome Treatment, Product Type & Application
2.7 Dry Eye Syndrome Treatment Market Competitive Situation and Trends
2.7.1 Dry Eye Syndrome Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dry Eye Syndrome Treatment Players Market Share by Revenue
2.7.3 Global Dry Eye Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dry Eye Syndrome Treatment Retrospective Market Scenario by Region
3.1 Global Dry Eye Syndrome Treatment Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dry Eye Syndrome Treatment Global Dry Eye Syndrome Treatment Sales by Region: 2019-2030
3.2.1 Global Dry Eye Syndrome Treatment Sales by Region: 2019-2024
3.2.2 Global Dry Eye Syndrome Treatment Sales by Region: 2025-2030
3.3 Global Dry Eye Syndrome Treatment Global Dry Eye Syndrome Treatment Revenue by Region: 2019-2030
3.3.1 Global Dry Eye Syndrome Treatment Revenue by Region: 2019-2024
3.3.2 Global Dry Eye Syndrome Treatment Revenue by Region: 2025-2030
3.4 North America Dry Eye Syndrome Treatment Market Facts & Figures by Country
3.4.1 North America Dry Eye Syndrome Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dry Eye Syndrome Treatment Sales by Country (2019-2030)
3.4.3 North America Dry Eye Syndrome Treatment Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dry Eye Syndrome Treatment Market Facts & Figures by Country
3.5.1 Europe Dry Eye Syndrome Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dry Eye Syndrome Treatment Sales by Country (2019-2030)
3.5.3 Europe Dry Eye Syndrome Treatment Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dry Eye Syndrome Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Dry Eye Syndrome Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dry Eye Syndrome Treatment Sales by Country (2019-2030)
3.6.3 Asia Pacific Dry Eye Syndrome Treatment Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dry Eye Syndrome Treatment Market Facts & Figures by Country
3.7.1 Latin America Dry Eye Syndrome Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dry Eye Syndrome Treatment Sales by Country (2019-2030)
3.7.3 Latin America Dry Eye Syndrome Treatment Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dry Eye Syndrome Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Dry Eye Syndrome Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dry Eye Syndrome Treatment Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dry Eye Syndrome Treatment Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Dry Eye Syndrome Treatment Sales by Type (2019-2030)
4.1.1 Global Dry Eye Syndrome Treatment Sales by Type (2019-2024)
4.1.2 Global Dry Eye Syndrome Treatment Sales by Type (2025-2030)
4.1.3 Global Dry Eye Syndrome Treatment Sales Market Share by Type (2019-2030)
4.2 Global Dry Eye Syndrome Treatment Revenue by Type (2019-2030)
4.2.1 Global Dry Eye Syndrome Treatment Revenue by Type (2019-2024)
4.2.2 Global Dry Eye Syndrome Treatment Revenue by Type (2025-2030)
4.2.3 Global Dry Eye Syndrome Treatment Revenue Market Share by Type (2019-2030)
4.3 Global Dry Eye Syndrome Treatment Price by Type (2019-2030)
5 Segment by Application
5.1 Global Dry Eye Syndrome Treatment Sales by Application (2019-2030)
5.1.1 Global Dry Eye Syndrome Treatment Sales by Application (2019-2024)
5.1.2 Global Dry Eye Syndrome Treatment Sales by Application (2025-2030)
5.1.3 Global Dry Eye Syndrome Treatment Sales Market Share by Application (2019-2030)
5.2 Global Dry Eye Syndrome Treatment Revenue by Application (2019-2030)
5.2.1 Global Dry Eye Syndrome Treatment Revenue by Application (2019-2024)
5.2.2 Global Dry Eye Syndrome Treatment Revenue by Application (2025-2030)
5.2.3 Global Dry Eye Syndrome Treatment Revenue Market Share by Application (2019-2030)
5.3 Global Dry Eye Syndrome Treatment Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Dry Eye Syndrome Treatment Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Corporation Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Allergan Dry Eye Syndrome Treatment Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 Otsuka
6.3.1 Otsuka Corporation Information
6.3.2 Otsuka Description and Business Overview
6.3.3 Otsuka Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Otsuka Dry Eye Syndrome Treatment Product Portfolio
6.3.5 Otsuka Recent Developments/Updates
6.4 Santen Pharmaceutical
6.4.1 Santen Pharmaceutical Corporation Information
6.4.2 Santen Pharmaceutical Description and Business Overview
6.4.3 Santen Pharmaceutical Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Santen Pharmaceutical Dry Eye Syndrome Treatment Product Portfolio
6.4.5 Santen Pharmaceutical Recent Developments/Updates
6.5 Nicox
6.5.1 Nicox Corporation Information
6.5.2 Nicox Description and Business Overview
6.5.3 Nicox Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Nicox Dry Eye Syndrome Treatment Product Portfolio
6.5.5 Nicox Recent Developments/Updates
6.6 Auven Therapeutics
6.6.1 Auven Therapeutics Corporation Information
6.6.2 Auven Therapeutics Description and Business Overview
6.6.3 Auven Therapeutics Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Auven Therapeutics Dry Eye Syndrome Treatment Product Portfolio
6.6.5 Auven Therapeutics Recent Developments/Updates
6.7 Akorn
6.6.1 Akorn Corporation Information
6.6.2 Akorn Description and Business Overview
6.6.3 Akorn Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Akorn Dry Eye Syndrome Treatment Product Portfolio
6.7.5 Akorn Recent Developments/Updates
6.8 Bausch & Lomb
6.8.1 Bausch & Lomb Corporation Information
6.8.2 Bausch & Lomb Description and Business Overview
6.8.3 Bausch & Lomb Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bausch & Lomb Dry Eye Syndrome Treatment Product Portfolio
6.8.5 Bausch & Lomb Recent Developments/Updates
6.9 Alimera
6.9.1 Alimera Corporation Information
6.9.2 Alimera Description and Business Overview
6.9.3 Alimera Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Alimera Dry Eye Syndrome Treatment Product Portfolio
6.9.5 Alimera Recent Developments/Updates
6.10 GlaxoSmithKline
6.10.1 GlaxoSmithKline Corporation Information
6.10.2 GlaxoSmithKline Description and Business Overview
6.10.3 GlaxoSmithKline Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)
6.10.4 GlaxoSmithKline Dry Eye Syndrome Treatment Product Portfolio
6.10.5 GlaxoSmithKline Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dry Eye Syndrome Treatment Industry Chain Analysis
7.2 Dry Eye Syndrome Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dry Eye Syndrome Treatment Production Mode & Process
7.4 Dry Eye Syndrome Treatment Sales and Marketing
7.4.1 Dry Eye Syndrome Treatment Sales Channels
7.4.2 Dry Eye Syndrome Treatment Distributors
7.5 Dry Eye Syndrome Treatment Customers
8 Dry Eye Syndrome Treatment Market Dynamics
8.1 Dry Eye Syndrome Treatment Industry Trends
8.2 Dry Eye Syndrome Treatment Market Drivers
8.3 Dry Eye Syndrome Treatment Market Challenges
8.4 Dry Eye Syndrome Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
